Follow the people · Insider

WY

Weiguo Ye

Insider · Chief Operating Officer · GYRE

Weiguo Ye files insider transactions with the SEC as a chief operating officer of Gyre Therapeutics (GYRE). We hold 16 disclosed purchases and sales filed since 22 November 2023, 6 of them in the last 90 days.

  • Files forGYRE
  • Disclosed buys and sells16 in all, 6 in the last 90 days
  • Last disclosure22 June 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 20 November 202318 June 2026Chief Operating Officer · Gyre Therapeutics (GYRE)58 Form 4 lines · source: SEC Form 4

Everything they disclosed

58 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.